EnsoData uses artificial intelligence to automate waveform analysis and spotlight disease processes as they manifest over different timescales. Their software analyzes clinical data within waveforms to aid in diagnosing, monitoring, and managing non-malignant, acute, and chronic debilitating diseases. Applications include monitoring patient health in the ICU, wearables data analysis, seizure detection, and earlier detection of heart disease, diabetes, stroke, and Alzheimer's disease.

Their first solution, EnsoSleep, focuses on sleep medicine and reduces the time required to score sleep studies. Leveraging a database of more than 2.5 million sleep studies, EnsoData's machine learning engine automates one of the most arduous tasks in healthcare: sleep study scoring. The company's goal is to provide AI-powered software that saves costs and time for clinicians, allowing more patient interaction and improving patient and provider satisfaction along with outcomes.

EnsoData is committed to diversity, equity, and inclusion, building a diverse team reflective of the populations they serve, strengthening underserved communities through volunteering and activism, and fostering education on these values within their community.